XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Balance, beginning of period at Sep. 30, 2023 $ 2,426,426 $ 300,000 $ 136,467 $ 1,687,634 $ 1,867,749 $ 46,921 $ (1,612,345)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 74,341       74,341    
Other comprehensive income (loss) 5,014         5,014  
Dividends on common stock (32,472)       (32,472)    
Dividends on preferred stock (7,313)       (7,313)    
Stock issued in merger 465,504   17,089 448,415      
Proceeds from stock issuances 2,530   95 2,435      
Stock-based compensation expense 5,180   184 4,859     137
Treasury stock purchased (17,304)           (17,304)
Balance, end of period at Mar. 31, 2024 2,921,906 300,000 153,835 2,143,343 1,902,305 51,935 (1,629,512)
Balance, beginning of period at Dec. 31, 2023 2,452,004 300,000 136,679 1,691,102 1,906,557 47,014 (1,629,348)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 15,888       15,888    
Other comprehensive income (loss) 4,921         4,921  
Dividends on common stock (16,484)       (16,484)    
Dividends on preferred stock (3,656)       (3,656)    
Stock issued in merger 465,504   17,089 448,415      
Proceeds from stock issuances 1,082   40 1,042      
Stock-based compensation expense 2,885   27 2,784     74
Treasury stock purchased (238)           (238)
Balance, end of period at Mar. 31, 2024 2,921,906 300,000 153,835 2,143,343 1,902,305 51,935 (1,629,512)
Balance, beginning of period at Sep. 30, 2024 3,000,300 300,000 154,007 2,150,675 1,978,898 55,851 (1,639,131)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 103,519       103,519    
Other comprehensive income (loss) (4,447)         (4,447)  
Dividends on common stock (42,541)       (42,541)    
Dividends on preferred stock (7,313)       (7,313)    
Proceeds from stock issuances 3,423   115 3,308      
Stock-based compensation expense 4,430   233 4,054     143
Treasury stock purchased (24,751)           (24,751)
Balance, end of period at Mar. 31, 2025 3,032,620 300,000 154,355 2,158,037 2,032,563 51,404 (1,663,739)
Balance, beginning of period at Dec. 31, 2024 3,021,636 300,000 154,248 2,154,929 2,001,586 53,353 (1,642,480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 56,252       56,252    
Other comprehensive income (loss) (1,949)         (1,949)  
Dividends on common stock (21,619)       (21,619)    
Dividends on preferred stock (3,656)       (3,656)    
Proceeds from stock issuances 718   26 692      
Stock-based compensation expense 2,579   81 2,416     82
Treasury stock purchased (21,341)           (21,341)
Balance, end of period at Mar. 31, 2025 $ 3,032,620 $ 300,000 $ 154,355 $ 2,158,037 $ 2,032,563 $ 51,404 $ (1,663,739)